142 related articles for article (PubMed ID: 21457557)
21. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
Arima Y; Inoue Y; Shibata T; Hayashi H; Nagano O; Saya H; Taya Y
Cancer Res; 2008 Jul; 68(13):5104-12. PubMed ID: 18593909
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
[TBL] [Abstract][Full Text] [Related]
23. Insulin-degrading enzyme higher in subjects with metabolic syndrome.
Sofer Y; Nash Y; Osher E; Fursht O; Goldsmith G; Nahary L; Shaklai S; Tordjman KM; Serebro M; Touati EB; Yacobi Bach M; Marcus Y; Tal B; Sack J; Shefer G; Margaliot M; Landis N; Goldiner I; Abu Ahmad W; Stern N; Benhar I; Frenkel D
Endocrine; 2021 Feb; 71(2):357-364. PubMed ID: 33398768
[TBL] [Abstract][Full Text] [Related]
24. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
25. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia.
Yki-Järvinen H; Taskinen MR
Diabetes; 1988 Sep; 37(9):1271-8. PubMed ID: 3044892
[TBL] [Abstract][Full Text] [Related]
26. Modulation of insulin degrading enzyme activity and liver cell proliferation.
Pivovarova O; von Loeffelholz C; Ilkavets I; Sticht C; Zhuk S; Murahovschi V; Lukowski S; Döcke S; Kriebel J; de las Heras Gala T; Malashicheva A; Kostareva A; Lock JF; Stockmann M; Grallert H; Gretz N; Dooley S; Pfeiffer AF; Rudovich N
Cell Cycle; 2015; 14(14):2293-300. PubMed ID: 25945652
[TBL] [Abstract][Full Text] [Related]
27. New concepts in extracellular signaling for insulin action: the single gateway hypothesis.
Bergman RN
Recent Prog Horm Res; 1997; 52():359-85; discussion 385-7. PubMed ID: 9238859
[TBL] [Abstract][Full Text] [Related]
28. Proposed interaction between insulin and retinoblastoma protein.
Radulescu RT; Wendtner CM
J Mol Recognit; 1992 Dec; 5(4):132-7. PubMed ID: 1339481
[TBL] [Abstract][Full Text] [Related]
29. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
Cordes CM; Bennett RG; Siford GL; Hamel FG
Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R
Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692
[TBL] [Abstract][Full Text] [Related]
32. Metabolic stress in insulin's target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance.
Eriksson JW
FEBS Lett; 2007 Jul; 581(19):3734-42. PubMed ID: 17628546
[TBL] [Abstract][Full Text] [Related]
33. Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion.
Edgerton DS; Kraft G; Smith M; Farmer B; Williams PE; Coate KC; Printz RL; O'Brien RM; Cherrington AD
JCI Insight; 2017 Mar; 2(6):e91863. PubMed ID: 28352665
[TBL] [Abstract][Full Text] [Related]
34. Abnormalities of retinoblastoma gene structure in human lung tumors.
Linardopoulos S; Gonos ES; Spandidos DA
Cancer Lett; 1993 Jul; 71(1-3):67-74. PubMed ID: 8103420
[TBL] [Abstract][Full Text] [Related]
35. In vitro degradation of insulin-like peptide 3 by insulin-degrading enzyme.
Zhang WJ; Luo X; Guo ZY
Protein J; 2010 Feb; 29(2):93-8. PubMed ID: 20082125
[TBL] [Abstract][Full Text] [Related]
36. Modulation of aromatase and P450 cholesterol side-chain cleavage enzyme activities of human placental cytotrophoblasts by insulin and insulin-like growth factor I.
Nestler JE
Endocrinology; 1987 Nov; 121(5):1845-52. PubMed ID: 3311719
[TBL] [Abstract][Full Text] [Related]
37. Molecular genetics of the retinoblastoma suppressor gene.
Bookstein R; Lee WH
Crit Rev Oncog; 1991; 2(3):211-27. PubMed ID: 1888791
[TBL] [Abstract][Full Text] [Related]
38. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
Qiu WQ; Folstein MF
Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
[TBL] [Abstract][Full Text] [Related]
39. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
40. Insulin antagonism of catecholamine stimulation of fatty acid transport in the adipocyte. Studies on its mechanism of action.
Abumrad NA; Harmon CM; Barnela US; Whitesell RR
J Biol Chem; 1988 Oct; 263(29):14678-83. PubMed ID: 2459120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
